Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France.

Colson P, Henry M, Motte A, Gallais H, Moreau J, Poizot-Martin I, Tamalet C.

Eur J Epidemiol. 2006;21(8):615-8. Epub 2006 Sep 20.

PMID:
17031520
2.

Medically assisted procreation and transmission of hepatitis C virus: absence of HCV RNA in purified sperm fraction in HIV co-infected patients.

Halfon P, Giorgetti C, Bourlière M, Chabert-Orsoni V, Khiri H, Pénaranda G, Chincholle JM, Gallais H, Ravaux I, Moreau J, Gastaud JA, Roulier R.

AIDS. 2006 Jan 9;20(2):241-6.

PMID:
16511417
3.

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group.

Antivir Ther. 2005;10(1):53-61.

PMID:
15751763
4.

Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.

Colson P, Henry M, Tivoli N, Gallais H, Gastaut JA, Moreau J, Tamalet C.

J Med Virol. 2005 Mar;75(3):381-90.

PMID:
15648062
5.

Drug injection cessation among HIV-infected injecting drug users.

Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y; MANIF 2000 Study Group.

Addict Behav. 2004 Aug;29(6):1189-97.

PMID:
15236822
6.

Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.

Rey D, Carrieri MP, Spire B, Loubière S, Dellamonica P, Gallais H, Cassuto GP, Gastaut JA, Obadia Y; MANIF 2000 Study Group.

J Urban Health. 2004 Mar;81(1):48-57.

7.

[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].

Montana M, Chochoi N, Monges P, Ravaux I, Faraut F, Gensollen S, Bongrand MC, Timon-David P, Gallais H.

Pathol Biol (Paris). 2004 Mar;52(2):66-75. Review. French.

PMID:
15001234
8.

Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France.

Colson P, Henry M, Tourres C, Lozachmeur D, Gallais H, Gastaut JA, Moreau J, Tamalet C.

J Clin Microbiol. 2004 Feb;42(2):570-7.

9.

Nonadherence among HIV-infected injecting drug users: the impact of social instability.

Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, Obadia Y, Spire B; MANIF 2000 Study Group.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S149-53.

PMID:
12562040
10.

Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users.

Bouhnik AD, Moatti JP, Vlahov D, Gallais H, Dellamonica P, Obadia Y; MANIF 2000 Study Group.

J Epidemiol Community Health. 2002 May;56(5):349-53.

11.

High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen.

Solas C, Basso S, Poizot-Martin I, Ravaux I, Gallais H, Gastaut JA, Durand A, Lacarelle B.

J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):374-7.

PMID:
11917242
12.

Transmission of HIV-1 variants resistant to the three classes of antiretroviral agents: implications for HIV therapy in primary infection.

Colson P, Ravaux I, Yahi N, Tourrès C, Gallais H, Tamalet C.

AIDS. 2002 Feb 15;16(3):507-9. No abstract available.

PMID:
11834974
13.

[Pharmacologic dependence on nefopam (Acupan): a case report].

Spadari M, Tissot-Dupont H, Tichadou L, Arditti J, Jouglard J, David JM, Gallais H, Valli M.

Therapie. 2001 Mar-Apr;56(2):191-3. French. No abstract available.

PMID:
11471375
14.

Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin.

Amirayan-Chevillard N, Tissot-Dupont H, Obadia Y, Gallais H, Mege JL, Capo C.

Clin Diagn Lab Immunol. 2000 Sep;7(5):832-4.

15.

Rickettsia mongolotimonae: a rare pathogen in France.

Fournier PE, Tissot-Dupont H, Gallais H, Raoult DR.

Emerg Infect Dis. 2000 May-Jun;6(3):290-2.

16.

Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. The Manif-2000 Study Group.

Carrieri MP, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y.

Drug Alcohol Depend. 2000 Jul 1;60(1):51-4.

PMID:
10821989
17.

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.

Tamalet C, Pasquier C, Yahi N, Colson P, Poizot-Martin I, Lepeu G, Gallais H, Massip P, Puel J, Izopet J.

J Med Virol. 2000 Jun;61(2):181-6.

PMID:
10797372
18.

Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients.

Amirayan-Chevillard N, Tissot-Dupont H, Capo C, Brunet C, Dignat-George F, Obadia Y, Gallais H, Mege JL.

Clin Exp Immunol. 2000 Apr;120(1):107-12.

19.

Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.

Yahi N, Tamalet C, Tourrès C, Tivoli N, Ariasi F, Volot F, Gastaut JA, Gallais H, Moreau J, Fantini J.

J Clin Microbiol. 1999 Dec;37(12):4099-106.

20.

[Multiple and bilateral nodular opacities revealing primary pulmonary lymphoma of the Burkitt-like type in AIDS].

Débat Zoguéreh D, Ravaux I, Horshowski N, Gallais H.

Rev Pneumol Clin. 1999 Jun;55(3):182-6. French.

PMID:
10486841
21.

Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals.

André P, Brunet C, Guia S, Gallais H, Sampol J, Vivier E, Dignat-George F.

Eur J Immunol. 1999 Apr;29(4):1076-85.

22.

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.

Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Ciraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C, Delfraissy JF, Blanche S.

J Pediatr. 1997 Dec;131(6):857-62.

PMID:
9427890
23.

Foscarnet-induced hypercalcaemia in AIDS.

Gayet S, Ville E, Durand JM, Mars ME, Morange S, Kaplanski G, Gallais H, Soubeyrand J.

AIDS. 1997 Jul;11(8):1068-70. No abstract available.

PMID:
9223751
24.

Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group.

De Vincenzi I, Jadand C, Couturier E, Brunet JB, Gallais H, Gastaut JA, Goujard C, Deveau C, Meyer L.

AIDS. 1997 Mar;11(3):333-8.

PMID:
9147425
25.

Ethical dilemmas in care for HIV infection among French general practitioners.

Moatti JP, Souville M, Obadia Y, Morina M, Sebbah R, Gamby T, Gallais H, Gastaut JA.

Health Policy. 1995 Mar;31(3):197-210. Review.

PMID:
10142616
26.

[Evaluation of medication costs in hospitalization of AIDS patients].

Somme V, Flori A, Bouchet B, Bues-Charbit M, Balansard G, Gallais H.

J Pharm Belg. 1994 Nov-Dec;49(6):479-97. French.

PMID:
7884637
27.

Cutaneous biopsies for diagnosis of histoplasmosis in an HIV patient.

Petit N, Bonnet E, Chapel F, Bensa P, Gallais H, Lebreuil G.

Infection. 1994 Nov-Dec;22(6):426-7. No abstract available.

PMID:
7698844
28.

Clarithromycin: a potent agent against infections due to Mycobacterium marinum.

Bonnet E, Debat-Zoguereh D, Petit N, Ravaux I, Gallais H.

Clin Infect Dis. 1994 Apr;18(4):664-6. No abstract available.

PMID:
8038339
29.

[Familial deficiency of C7 associated with adrenomyeloneuropathy].

Pelletier J, Pestre P, ali Chérif A, Drancourt M, Gallais H, Khalil R.

Rev Neurol (Paris). 1994;150(1):78-80. French.

PMID:
7801048
30.

Rhodococcus equi infection in patients with AIDS.

Drancourt M, Bonnet E, Gallais H, Peloux Y, Raoult D.

J Infect. 1992 Mar;24(2):123-31. Review.

PMID:
1569304
31.

[Peripheral neuropathy in HTLV-I-associated myelopathy].

Pestre P, Olivares JP, Planche D, Pellissier JF, Gallais H.

Presse Med. 1991 Nov 30;20(41):2109. French. No abstract available.

PMID:
1662379
32.

[Fever on return from a tropical country. Diagnostic orientation].

Gallais H.

Rev Prat. 1991 Nov 15;41(24):2486-8. French. No abstract available.

PMID:
1803462
33.

[Tuberculosis in human immunodeficiency virus infection. 22 cases].

Pestre P, Sellier P, Bonnet E, Gallais H.

Presse Med. 1991 Sep 28;20(30):1416-20. French.

PMID:
1835023
34.

[Hemichorea in acquired immunodeficiency syndrome. Toxoplasmosis abscess in the striatum].

Pestre P, Milandre L, Farnarier P, Gallais H.

Rev Neurol (Paris). 1991;147(12):833-7. Review. French.

PMID:
1780613
35.

[Lessons of the socioeconomic structure of a cohort of 50 drug addicts infected with HIV and followed up over a year].

Pène P, Gallais H, Chaudet H, Clouet MN.

Bull Acad Natl Med. 1990 Nov;174(8):1141-8; discussion 1149. French.

PMID:
2128822
36.

[Pneumonia in AIDS: a case of co-infection caused by Toxoplasma gondii and Pneumocystis carinii].

Levy PY, Brouqui P, Dumon H, Gallais H.

Presse Med. 1990 Apr 7;19(14):673. French. No abstract available.

PMID:
2139953
37.

Chronic Q fever: diagnosis and follow-up.

Raoult D, Levy PY, Harlé JR, Etienne J, Massip P, Goldstein F, Micoud M, Beytout J, Gallais H, Remy G, et al.

Ann N Y Acad Sci. 1990;590:51-60.

PMID:
2378473
38.

Biological variations in 412 patients with Mediterranean spotted fever.

Drancourt M, Raoult D, Harlé JR, Chaudet H, Janbon F, Charrel C, Gallais H.

Ann N Y Acad Sci. 1990;590:39-50. No abstract available.

PMID:
2378466
39.

Pneumonia and meningitis caused by a new nonfermentative unknown gram-negative bacterium.

Casalta JP, Peloux Y, Raoult D, Brunet P, Gallais H.

J Clin Microbiol. 1989 Jul;27(7):1446-8.

40.

Osteoarticular infection due to Coxiella burnetii.

Raoult D, Bollini G, Gallais H.

J Infect Dis. 1989 Jun;159(6):1159-60. No abstract available.

PMID:
2723460
41.

[Coexistence of HIV-1 and HTLV-1 infections in Marseilles].

Tamalet C, Rousseau S, Benaim C, Gallais H, Tamalet J.

Presse Med. 1989 Feb 4;18(4):180. French. No abstract available.

PMID:
2522202
42.

[Major thrombocytopenia related to HIV1 virus treated with zidovudine].

Routy JP, Finaud M, Blanc AP, Gastaut JA, Gallais H, Tamalet J, Casanova P.

Presse Med. 1988 Oct 1;17(33):1703. French. No abstract available.

PMID:
2973035
43.

Ofloxacin penetration into cerebrospinal fluid.

Drancourt M, Gallais H, Raoult D, Estrangin E, Mallet MN, De Micco P.

J Antimicrob Chemother. 1988 Aug;22(2):263-5. No abstract available.

PMID:
3182421
44.

[Familial deficiency of complement factor 7: association with bacterial meningitis. Apropos of 3 recent cases].

Drancourt M, Raoult D, Lesavre P, Gallais H, Casanova P.

Pathol Biol (Paris). 1988 Jun;36(6):825-8. French.

PMID:
3047643
45.

[Outcome of neurosyphilis in the development of acquired immunodeficiency syndrome].

Drancourt M, Raoult D, Tamalet C, Gallais H, Casanova P.

Presse Med. 1988 May 21;17(19):965. French. No abstract available.

PMID:
2967967
46.

[Primary gastroduodenal tuberculosis. Problems posed apropos of a case].

François GF, Giuly J, Gallais H, Casanova P, Meunier A, Docimo L.

Chirurgie. 1988;114(4):327-33. Review. French. No abstract available.

PMID:
3069377
47.

Haemophilus parainfluenzae meningitis in an adult with an inherited deficiency of the seventh component of complement.

Raoult D, Drancourt M, Gallais H, Casanova P, Lesavre P.

Arch Intern Med. 1987 Dec;147(12):2214. No abstract available.

PMID:
3689075
48.

Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.

Carbon C, Auboyer C, Becq-Giraudon B, Bertrand P, Gallais H, Mouton Y, Motin JP, Vachon F, Wasmer JM, Buré A, et al.

Chemioterapia. 1987 Jun;6(2 Suppl):367-8. No abstract available.

PMID:
3334576
49.

Immune complex vasculitis associated with mediterranean spotted fever.

De Micco C, Raoult D, Benderitter T, Gallais H, Toga M.

J Infect. 1987 Mar;14(2):163-5.

PMID:
2952736
50.

Coxiella burnetii infection of a vascular prosthesis.

Raoult D, Piquet P, Gallais H, de Micco C, Drancourt M, Casanova P.

N Engl J Med. 1986 Nov 20;315(21):1358-9. No abstract available.

PMID:
3773962

Supplemental Content

Loading ...
Support Center